Page last updated: 2024-08-17

levodopa and Mood Disorders

levodopa has been researched along with Mood Disorders in 26 studies

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19905 (19.23)18.7374
1990's3 (11.54)18.2507
2000's10 (38.46)29.6817
2010's8 (30.77)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hagell, P; Iwarsson, S; Nilsson, MH; Odin, P; Rosqvist, K; Storch, A1
Campos, FL; Carvalho, MM; Coimbra, B; Lima, R; Pêgo, JM; Rodrigues, AJ; Rodrigues, C; Salgado, AJ; Sousa, N1
Fujishiro, H; Kasanuki, K; Nakamura, S1
Cohen, AD; Liu, W; Ye, M; Zhang, N; Zhang, Y1
Ahn, MH; Chung, SJ; Hong, JP; Kim, J; Kim, MS; Lee, HB; Lee, T1
Fox, SH; Lang, AE1
Cho, JY; Cho, YJ; Hong, KS; Jeon, BS; Kim, HJ; Lee, DH; Park, SY; Seo, SY1
Artemova, IIu; Boĭko, AN; Ganzhula, PA; Ismailov, AM; Ivanov, AK; Khozova, AA; Levin, OS; Lisenker, LN; Nesterova, OS; Otcheskaia, OV; Rotor, LD; Vdovichenko, TV; Zhuravleva, EIu1
Delbari, A; Lokk, J; Salman-Roghani, R1
Evans, AH; Farrell, MJ; Gibson, SJ; Helme, RD; Lim, SY1
Sulkava, R1
Agid, Y; Bejjani, BP; Houeto, JL; Mallet, L; Mesnage, V; Welter, ML1
Agid, Y; Czernecki, V; Dubois, B; Houeto, JL; Mesnage, V; Pillon, B; Welter, ML1
Le Rhun, E; Lebert, F1
Cannas, A; Floris, G; Solla, P; Tacconi, P1
Durso, R; McNamara, P1
de Noordhout, AM; Santens, P1
Cardoso, FE; Kummer, A; Maia, DP; Salgado, JV; Teixeira, AL1
Dunner, DL1
Baum, R; Glantz, R; Klawans, HL; Nausieda, PA; Weber, S1
Prange, AJ1
Fetoni, V; Girotti, F; Monza, D; Soliveri, P; Testa, D1
Belichenko, PV; Orlova, EI; Tsaĭner, B1
Brown, RG; Gotham, AM; Marsden, CD; Nissenbaum, H; Quinn, NP; Toone, B1
Kamenetskiĭ, VK; Nuller, IuL1
Fonda, D1

Reviews

6 review(s) available for levodopa and Mood Disorders

ArticleYear
Levodopa-related motor complications--phenomenology.
    Movement disorders : official journal of the Movement Disorder Society, 2008, Volume: 23 Suppl 3

    Topics: Antiparkinson Agents; Cognition Disorders; Disease Progression; Drug Administration Schedule; Dyskinesias; Fatigue; Humans; Levodopa; Mood Disorders; Motor Activity; Parkinson Disease; Treatment Failure

2008
Differential diagnosis between early Parkinson's disease and dementia with Lewy bodies.
    Advances in neurology, 2003, Volume: 91

    Topics: Brain; Cognition Disorders; Diagnosis, Differential; Disease Progression; Hallucinations; Humans; Levodopa; Lewy Body Disease; Mood Disorders; Parkinson Disease

2003
[Treatment of dementia with Lewy bodies].
    Revue neurologique, 2006, Volume: 162, Issue:1

    Topics: Antiparkinson Agents; Antipsychotic Agents; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Case Management; Cholinesterase Inhibitors; Combined Modality Therapy; Drug Resistance; Drug Therapy, Combination; Hallucinations; Humans; Levodopa; Lewy Body Disease; Mental Disorders; Mood Disorders; Nootropic Agents; Physical Therapy Modalities; Sleep Wake Disorders; Speech Therapy

2006
Neuropharmacological treatment of mental dysfunction in Parkinson's disease.
    Behavioural neurology, 2006, Volume: 17, Issue:1

    Topics: Basal Ganglia; Cholinergic Agents; Cognition Disorders; Dopamine Agonists; Frontal Lobe; Humans; Levodopa; Mood Disorders; Norepinephrine; Parkinson Disease

2006
Novel uses of thyroid hormones in patients with affective disorders.
    Thyroid : official journal of the American Thyroid Association, 1996, Volume: 6, Issue:5

    Topics: Antidepressive Agents; Bipolar Disorder; Electroconvulsive Therapy; Female; Humans; Levodopa; Lithium; Male; Mood Disorders; Parkinson Disease; Thyroid Diseases; Thyroid Gland; Thyroid Hormones

1996
Parkinson's disease in the elderly: psychiatric manifestations.
    Geriatrics, 1985, Volume: 40, Issue:4

    Topics: Aged; Amantadine; Depression; Humans; Levodopa; Mood Disorders; Parasympatholytics; Parkinson Disease; Personality Disorders

1985

Trials

4 trial(s) available for levodopa and Mood Disorders

ArticleYear
The heterogeneity of non-motor symptoms of Parkinson's disease.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2015, Volume: 36, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Asian People; Digestive System Abnormalities; Female; Humans; Levodopa; Male; Mental Status Schedule; Metabolic Diseases; Middle Aged; Mood Disorders; Parkinson Disease; Retrospective Studies; Sensation Disorders; Severity of Illness Index; Sleep Wake Disorders; Young Adult

2015
[Effect of dopamine agonist pramipexole (mirapex) on tremor, affective disorders and quality of life in patients with Parkinson's disease].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2010, Volume: 110, Issue:2

    Topics: Adult; Aged; Benzothiazoles; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Mood Disorders; Parkinson Disease; Pramipexole; Quality of Life; Tremor

2010
Effect of methylphenidate and/or levodopa combined with physiotherapy on mood and cognition after stroke: a randomized, double-blind, placebo-controlled trial.
    European neurology, 2011, Volume: 66, Issue:1

    Topics: Aged; Analysis of Variance; Antiparkinson Agents; Central Nervous System Stimulants; Cognition Disorders; Double-Blind Method; Female; Humans; Levodopa; Male; Methylphenidate; Middle Aged; Mood Disorders; Neuropsychological Tests; Physical Therapy Modalities; Psychiatric Status Rating Scales; Retrospective Studies; Stroke; Time Factors; Treatment Outcome

2011
Affective symptoms in multiple system atrophy and Parkinson's disease: response to levodopa therapy.
    Journal of neurology, neurosurgery, and psychiatry, 1999, Volume: 66, Issue:4

    Topics: Antiparkinson Agents; Depression; Humans; Levodopa; Middle Aged; Mood Disorders; Multiple System Atrophy; Parkinson Disease

1999

Other Studies

16 other study(ies) available for levodopa and Mood Disorders

ArticleYear
Dopaminergic Effect on Non-Motor Symptoms in Late Stage Parkinson's Disease.
    Journal of Parkinson's disease, 2018, Volume: 8, Issue:3

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Cognition Disorders; Dopamine Agents; Fatigue; Female; Humans; Levodopa; Male; Mood Disorders; Parkinson Disease; Treatment Outcome

2018
Behavioral characterization of the 6-hydroxidopamine model of Parkinson's disease and pharmacological rescuing of non-motor deficits.
    Molecular neurodegeneration, 2013, Apr-26, Volume: 8

    Topics: Adrenergic Agents; Animals; Antidepressive Agents; Antiparkinson Agents; Behavior, Animal; Bupropion; Disease Models, Animal; Immunohistochemistry; Levodopa; Mood Disorders; Motor Activity; Oxidopamine; Parkinsonian Disorders; Paroxetine; Rats; Rats, Wistar

2013
Levodopa treatment and mood fluctuation in dementia with Lewy bodies: a case report.
    Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2013, Volume: 13, Issue:4

    Topics: Affect; Aged; Comorbidity; Dopamine Agents; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Levodopa; Lewy Body Disease; Mood Disorders; Treatment Outcome

2013
Increased suicide risk and clinical correlates of suicide among patients with Parkinson's disease.
    Parkinsonism & related disorders, 2016, Volume: 32

    Topics: Aged; Antiparkinson Agents; Case-Control Studies; Female; Humans; Levodopa; Male; Middle Aged; Mood Disorders; Parkinson Disease; Psychiatric Status Rating Scales; Retrospective Studies; Severity of Illness Index; Suicide

2016
Nonmotor symptoms in de novo Parkinson disease before and after dopaminergic treatment.
    Journal of the neurological sciences, 2009, Dec-15, Volume: 287, Issue:1-2

    Topics: Aged; Antiparkinson Agents; Benzothiazoles; Cognition Disorders; Comorbidity; Disability Evaluation; Dopamine Agonists; Female; Gastrointestinal Diseases; Humans; Indoles; Levodopa; Male; Memory Disorders; Middle Aged; Mood Disorders; Movement Disorders; Neurologic Examination; Nocturia; Outcome Assessment, Health Care; Parkinson Disease; Pramipexole; Prevalence; Restless Legs Syndrome; Treatment Outcome

2009
Dyskinetic patients show rebound worsening of affect after an acute L-dopa challenge.
    Parkinsonism & related disorders, 2012, Volume: 18, Issue:5

    Topics: Aged; Analysis of Variance; Antiparkinson Agents; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Mental Status Schedule; Middle Aged; Mood Disorders; Parkinson Disease; Regression Analysis; Severity of Illness Index; Time Factors

2012
Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up.
    Neurology, 2003, Jan-14, Volume: 60, Issue:1

    Topics: Confusion; Depression; Dopamine Agonists; Electric Stimulation Therapy; Follow-Up Studies; Levodopa; Mood Disorders; Neuroleptic Malignant Syndrome; Parkinson Disease; Quality of Life; Social Behavior Disorders; Substance Withdrawal Syndrome; Subthalamic Nucleus; Time; Treatment Outcome

2003
Does bilateral stimulation of the subthalamic nucleus aggravate apathy in Parkinson's disease?
    Journal of neurology, neurosurgery, and psychiatry, 2005, Volume: 76, Issue:6

    Topics: Antiparkinson Agents; Deep Brain Stimulation; Extinction, Psychological; Female; Functional Laterality; Humans; Levodopa; Male; Middle Aged; Mood Disorders; Motivation; Neurosurgical Procedures; Parkinson Disease; Reward; Severity of Illness Index; Subthalamic Nucleus

2005
Paraphilic behaviours in a parkinsonian patient with hedonistic homeostatic dysregulation.
    The international journal of neuropsychopharmacology, 2006, Volume: 9, Issue:6

    Topics: Antiparkinson Agents; Benserazide; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Homeostasis; Humans; Levodopa; Male; Middle Aged; Mood Disorders; Paraphilic Disorders; Parkinson Disease; Pedophilia; Pergolide

2006
Detection of motor and non-motor symptoms of end-of dose wearing-off in Parkinson's disease using a dedicated questionnaire: a Belgian multicenter survey.
    Acta neurologica Belgica, 2006, Volume: 106, Issue:3

    Topics: Aged; Antiparkinson Agents; Anxiety; Belgium; Humans; Levodopa; Mood Disorders; Movement Disorders; Parkinson Disease; Surveys and Questionnaires

2006
Dopamine dysregulation syndrome in Parkinson's disease: case report.
    Arquivos de neuro-psiquiatria, 2006, Volume: 64, Issue:4

    Topics: Aged; Antiparkinson Agents; Dopamine; Humans; Levodopa; Male; Mood Disorders; Parkinson Disease; Substance-Related Disorders; Syndrome

2006
Sub-types of bipolar affective disorder with particular regard to bipolar II.
    Psychiatric developments, 1983,Spring, Volume: 1, Issue:1

    Topics: Adult; Bipolar Disorder; Catechol O-Methyltransferase; Diagnosis, Differential; Humans; Levodopa; Lithium; Lithium Carbonate; Mood Disorders; Suicide, Attempted

1983
Psychiatric complications of levodopa therapy of Parkinson's disease.
    Advances in neurology, 1984, Volume: 40

    Topics: Circadian Rhythm; Hallucinations; Humans; Hydrocortisone; Levodopa; Mental Disorders; Mood Disorders; Parkinson Disease; Sleep Initiation and Maintenance Disorders; Sleep Wake Disorders; Thinking

1984
[Biochemical aspects of the pathogenesis of autonomic and emotional disorders in functional disorders of the dopamine system].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1991, Volume: 91, Issue:12

    Topics: Animals; Autonomic Nervous System Diseases; Choline O-Acetyltransferase; Cholinesterase Inhibitors; Disease Models, Animal; Dopamine; Hypothalamus; Levodopa; Male; Mood Disorders; Parasympathetic Nervous System; Rats; Rats, Inbred Strains; Synaptosomes

1991
Mood swings associated with the 'on-off' phenomenon in Parkinson's disease.
    Psychological medicine, 1987, Volume: 17, Issue:4

    Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Depressive Disorder; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Mood Disorders; Parkinson Disease; Parkinson Disease, Secondary

1987
[Features of affective disorders in patients with vascular parkinsonism].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1987, Volume: 87, Issue:4

    Topics: Aged; Anxiety; Cerebrovascular Disorders; Depression; Drug Therapy, Combination; Humans; Levodopa; Middle Aged; Mood Disorders; Parasympatholytics; Parkinson Disease, Secondary

1987